An epidermal growth factor receptor compound mutation of L858R with S768I in advanced non-small-cell lung cancer: a case report

An epidermal growth factor receptor compound mutation of L858R with S768I in advanced non-small-cell lung cancer: a case report

Abstract Background In the current treatment landscape for non-small cell lung cancers, epidermal growth factor receptor-tyrosine kinase inhibitors have emerged as a well-established treatment option for patients with advanced or metastatic disease. This is particularly true for those with commonly...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Sara Boukansa, Ismail Mouhrach, Fatima El Agy, Laila Bouguenouch, Mounia Serraj, Bouchra Amara, Yassine Ouadnouni, Mohamed Smahi, Badreeddine Alami, Nawfel Mellas, Zineb Benbrahim, Hinde El Fatemi
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: BMC 2024-03-01
Loạt:Journal of Medical Case Reports
Những chủ đề:
EGFR mutation
L858R
S768I
Afatinib
Case report
Truy cập trực tuyến:https://doi.org/10.1186/s13256-024-04422-5

Internet

https://doi.org/10.1186/s13256-024-04422-5

Những quyển sách tương tự